Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 386 KiB)
Jonasch, E.; Atkins, M.B.; Chowdhury, S.; Mainwaring, P. Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts? Cancers 2022, 14, 644. https://doi.org/10.3390/cancers14030644
Jonasch E, Atkins MB, Chowdhury S, Mainwaring P. Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts? Cancers. 2022; 14(3):644. https://doi.org/10.3390/cancers14030644
Chicago/Turabian StyleJonasch, Eric, Michael B. Atkins, Simon Chowdhury, and Paul Mainwaring. 2022. "Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?" Cancers 14, no. 3: 644. https://doi.org/10.3390/cancers14030644